~~<i id='9CD230D516'><strike id='9CD230D516'><tt id='9CD230D516'><pre id='9CD230D516'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

entertainment

author：knowledge 2025-10-01 18:33:00 - browse：4641

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

A couple billion here, a couple billion there, and pretty soon Eli Lilly hopes it will be talking about real money.

Eli Lilly agreed to purchase Point Biopharma Tuesday morning for $1.4 billion, a 90% premium, adding to its pipeline of cancer drugs. Point is developing cancer drugs that deliver a focused dose of radiation to tumor cells. Data for its lead medicine, for prostate cancer, are expected in the fourth quarter. It is also developing a drug for neuroendocrine tumors.

Point operates a 180,000-square-foot radiopharmaceutical manufacturing facility in Indianapolis, and a radiopharmaceutical research and development center in Toronto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Lung cancer is America's deadliest cancer. Yet so few get screened

leisure time

entertainment

focus

Wikipedia

knowledge

1:44AfterbabyEliwasdischargedfromthehospital,hisparents,TylerandIrveEdmond,drove18hoursfromNorthCaro

WSS

Parents surprise family after baby discharged from NICU after 170 days

Biden targets hefty hospital 'facility fees' that often surprise patients

ActiGraph execs on goal of drug approvals with digital endpoints

Swim instructor mom warns parents not to buy blue swimsuits for kids

Wisconsin governor employs partial veto to fund schools for 4 centuries

Liz Cheney makes 1st public comment since Trump's election interference indictments

leisure time

entertainment

leisure time

Sports medicine is finally prioritizing gender equality

Hilary may become 1st tropical storm to make landfall in California in 84 years

Psychedelics group wrestles with new pharma identity

Parents surprise family after baby discharged from NICU after 170 days

Medical leaders decry Supreme Court decision on affirmative action

Liz Cheney makes 1st public comment since Trump's election interference indictments

State Dept. review finds Biden bears some blame for Afghanistan failures

New details revealed about Purdue's marketing of OxyContin

Sports medicine is finally prioritizing gender equality

An interview with Robert F. Kennedy Jr. on vaccines

entertainment

Create a giant ice tray with this foil pan hack to keep food cold this summer

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

As Maui death toll rises, number of missing remains unclear

Congress must give Medicare recipients genetic counseling access

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

focus

focus

Wikipedia

knowledge